Sales & Earnings In Brief: Revlon, Reckitt, Kao Report At Half-Year Mark
This article was originally published in The Rose Sheet
Revlon remains optimistic that investments in its Almay brand will deliver, despite the brand’s struggling performance in the second quarter. More financial news in brief.
You may also be interested in...
Reckitt Benckiser says it will focus on its consumer health business, led by the Mucinex OTC decongestant line, and other core units with strong sales and will review its slumping Rx business, including considering a sale.
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.